References
Yamamoto T, Allan RN, Keighley MR (2001) Long-term outcome of surgical management for diffuse jejunoileal Crohn’s disease. Surgery 129:96–102
Nakahigashi M, Yamamoto T (2011) Increases in body mass index during infliximab therapy in patients with Crohn’s disease: an open label prospective study. Cytokine 56:531–535
Franchimont D, Roland S, Gustot T, Quertinmont E, Toubouti Y, Gervy MC, Deviere J, Van Gossum A (2005) Impact of infliximab on serum leptin levels in patients with Crohn’s disease. J Clin Endocrinol Metab 90:3510–3516
Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA (2006) Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 12:100–105
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matsuda, S., Bamba, T., Sohma, S. et al. Postoperative infliximab and elemental diet combination in a case with diffuse, extensive jejunoileal Crohn’s disease. Int J Colorectal Dis 29, 265–266 (2014). https://doi.org/10.1007/s00384-013-1777-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-013-1777-7